Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Key Points: Cas9 editing of the γ-globin gene promoters in hematopoietic stem cells (HSCs) increases red cell HbF by ≤40%. No deleterious effects on hematopoiesis or off-target mutations were detected 16 weeks after xenotransplantation of edited HSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“They include disrupting the erythroid enhancer of BCL11A or the binding sites for BCL11A in the g-globin gene promoters.126”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390
Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510865 · Cited by 1,488
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Lin, S., Staahl, B. T., Alla, R. K., & Doudna, J. A. (2014) · eLife · doi:10.7554/elife.04766 · Cited by 1,189
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld, I., Lunstad, B. D., Kaiser, R. J., Wilkens, A. B., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3290 · Cited by 1,090
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886
Self-citationCRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., et al. (2016) · Nature · doi:10.1038/nature20134 · Cited by 864
Self-citationCIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets
Tsai, S. Q., Nguyen, N. T., Malagon-Lopez, J., Topkar, V. V., Aryee, M. J., & Joung, J. K. (2017) · Nature Methods · doi:10.1038/nmeth.4278 · Cited by 814
Self-citationPiel, F. B., Steinberg, M., & Rees, D. C. (2016) · Spiral (Imperial College London) · doi:10.1056/nejmc1706325#sa6 · Cited by 659
Six Classes of Nuclear Localization Signals Specific to Different Binding Grooves of Importin α
Kosugi, S., Hasebe, M., Matsumura, N., Takashima, H., Miyamoto-Sato, E., Tomita, M., & Yanagawa, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807017200 · Cited by 615
Cited by
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
Leibowitz, M. L., Papathanasiou, S., Doerfler, P. A., Blaine, L. J., Sun, L., Yao, Y., Zhang, C.-Z., Weiss, M. J., & Pellman, D. (2021) · Nature Genetics · doi:10.1038/s41588-021-00838-7 · Cited by 583
Self-citationde Klein, N., Tsai, E. A., Vochteloo, M., Baird, D., Huang, Y., Chen, C.-Y., van Dam, S., Oelen, R., Deelen, P., Bakker, O. B., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01300-6 · Cited by 272
Gene therapy using haematopoietic stem and progenitor cells
Ferrari, G., Thrasher, A. J., & Aiuti, A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00298-5 · Cited by 254
Piel, F. B., Rees, D. C., DeBaun, M. R., Nnodu, O., Ranque, B., Thompson, A. A., Ware, R. E., Abboud, M. R., Abraham, A., Ambrose, E. E., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00096-0 · Cited by 177
Self-citationCRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
Sharma, A., Boelens, J.-J., Cancio, M., Hankins, J. S., Bhad, P., Azizy, M., Lewandowski, A., Zhao, X., Chitnis, S., Peddinti, R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2215643 · Cited by 182
Self-citation
Metadata
- Authors
- Métais, J.-Y., Doerfler, P. A., Mayuranathan, T., Bauer, D. E., Fowler, S. C., Hsieh, M. M., Katta, V., Keriwala, S., Lazzarotto, C. R., Luk, K., Neel, M. D., Perry, S. S., Peters, S. T., Porter, S. N., Ryu, B. Y., Sharma, A., Shea, D., Tisdale, J. F., Uchida, N., Wolfe, S. A., Woodard, K. J., Wu, Y., Yao, Y., Zeng, J., Pruett-Miller, S., Tsai, S. Q., & Weiss, M. J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Broad Institute (US)
- National Heart, Lung, and Blood Institute (US)
- Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN;
- University of Massachusetts Chan Medical School (US)
- Division of Orthopedics,
- Flow Cytometry and Cell Sorting Shared Resource,
- Department of Cell and Molecular Biology, and
- Boston Children's Hospital (US)
- ORCID
- Métais, Jean-Yves
- Doerfler, Phillip A.
- Mayuranathan, Thiyagaraj
- Bauer, Daniel E.
- Hsieh, Matthew M.
- Katta, Varun
- Luk, Kevin
- Neel, Michael D.
- Sharma, Akshay
- Shea, Devlin
- Tisdale, John F.
- Uchida, Naoya
- Wolfe, Scot A.
- Woodard, Kaitly J.
- Wu, Yuxuan
- Yao, Yu
- Zeng, Jing
- Pruett-Miller, Shondra
- Tsai, Shengdar Q.
- Weiss, Mitchell J.
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2019-11-06
- Volume
- 3
- Issue
- 21
- Pages
- 3379-3392
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- PMC
- PMC6855127
- OpenAlex
- W2983573843
- Semantic Scholar
- 751a307399957e94e5f73a09f06da3c1a7e2c4b3
- Cited by
- 177
- References
- 56
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 24 · 2023: 30 · 2022: 32 · 2021: 34 · 2020: 18
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Blood Advances (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Doris Duke Charitable Foundation (2017093)
- Assisi Foundation of Memphis
- St. Jude Children's Research Hospital (CA21765)
- American Lebanese Syrian Associated Charities (CA 21765)
- National Institutes of Health (CA21765))
- National Heart, Lung, and Blood Institute (P01HL053749, HL053749, U01HL145793)
- National Cancer Institute (CA21765, P 30CA 21765, P30CA021765)
- National Institute of General Medical Sciences (R01GM115911, CA21765)
- National Institute of Allergy and Infectious Diseases (R01AI117839, U01AI157189)
- National Institute of Biomedical Imaging and Bioengineering (U01EB029373)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- genome editing, fetal hemoglobin induction, HBG1, HBG2, sickle cell disease, beta-thalassemia, CRISPR/Cas9, BCL11A, hematopoietic stem and progenitor cells, xenotransplantation, CIRCLE-seq, off-target mutations, nuclear localization signal, hemoglobinopathies
- MeSH terms
- Gene Editing, RNA, Guide, CRISPR-Cas Systems, Anemia, Sickle Cell, Animals, Base Sequence, Disease Models, Animal, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Hematopoietic Stem Cells, Hemoglobinopathies, Humans, Models, Biological, Mutation, Promoter Regions, Genetic, Immunophenotyping, Sequence Deletion, RNA, Guide, Kinetoplastida, Hematopoietic Stem Cell Transplantation, Gene Targeting, Mice, gamma-Globins, CRISPR-Cas Systems, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. https://app.cochat.ai/papers/10.1182/bloodadvances.2019000820
- The paper
- Métais, J.-Y., Doerfler, P. A., Mayuranathan, T., Bauer, D. E., Fowler, S. C., Hsieh, M. M., Katta, V., Keriwala, S., Lazzarotto, C. R., Luk, K., Neel, M. D., Perry, S. S., Peters, S. T., Porter, S. N., Ryu, B. Y., Sharma, A., Shea, D., Tisdale, J. F., Uchida, N., . . . Weiss, M. J. (2019). Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. Blood Advances. https://doi.org/10.1182/bloodadvances.2019000820
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.